Skip to main navigation
Skip Navigation
Landos Biopharma
  • - Landos - Corp Menu

  • About Us
    • Our Company
      • Management Team
      • Board of Directors
      • Clinical Advisory Board
    • Contact Us
  • Product Candidates
    • Our Pipeline
    • Preclinical Candidates
    • Clinical Trials
  • Science
    • LANCE Precision Medicine Platform
    • Immunometabolic Pathways
    • Publications
  • Investors/Media
    • Investor/Media Home
    • Press Releases
    • Events & Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Investors/Media FAQs
  • Careers
    • Why Landos?
    • Open Positions
Identifying novel pathways at the interface of immunity and metabolism

Press Releases

5/12/22
Landos Biopharma Reports First Quarter 2022 Results and Provides Business Update
3/24/22
Landos Biopharma Reports Fourth Quarter and Full Year 2021 Results and Provides Business Update
3/10/22
Landos Biopharma Appoints Roger Adsett to its Board of Directors

Investors/Media

Investor Relations

  • Investor/Media Home
  • Press Releases
  • Events & Presentations
  • Analyst Coverage
  • Stock Information
  • SEC Filings
  • Corporate Governance
  • Investors/Media FAQs

- Landos - Investor Tools

  • Print Page
  • RSS Feeds
  • Email Alerts

Contact

Landos Biopharma, Inc.
1800 Kraft Drive, Suite 216
Blacksburg, VA 24060
info@landosbiopharma.com
(540) 218-2232

- Landos - Footer Menu

  • Site Map
  • Terms of Use
  • Privacy Policy

©2022 Landos Biopharma All Rights Reserved.